Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

U. of Connecticut researchers describe CB1 modulators for obesity and other uses

April 11, 2003

Indan-based anorectic agents developed at Aventis

April 11, 2003

First-in-man study of Probiodrug DPP-IV inhibitor

April 10, 2003

ASCOT data demonstrate significant cardiovascular benefits for Lipitor

April 10, 2003

Choongwae will market mitiglinide in Korea

April 10, 2003

Worldwide status of Replagal updated by TKT

April 10, 2003

New benzothiazepine-based IBAT inhibitors discovered at AstraZeneca

April 10, 2003

Inotek claims PARP inhibitors with activity in inflammation, reperfusion and diabetes models

April 10, 2003

Dual LH and FSH receptor agonists discovered at Akzo Nobel

April 10, 2003

Obese patients enrolled in new phase IIb trial for BVT-933

April 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...